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Abstract.  Nucleocytoplasmic transport of fluorescent- 
labeled macromolecules was investigated  in trans- 
formed and nontransformed 3T3 fibroblasts.  Insulin 
and epidermal growth factor enhanced transport three- 
fold after 1-2-h  incubation with nontransformed adher- 
ing fibroblasts; no enhancement of transport was ob- 
served for spherical unattached fibroblasts.  The 
concentration of growth factor for maximal enhance- 
ment was 3-10 nM. Nuclear transport for Kirsten mu- 
rine sarcoma virus-transformed BALB/c 3T3 fibro- 
blasts, however,  was maximally enhanced before addi- 
tion of growth factors; addition of insulin or epidermal 
growth factor causes no additional transport enhance- 
ment. Transformation also minimizes cell shape effects 
on macromolecular nuclear transport. These results 
provide evidence that protein growth factors and onco- 
genic transformation may use a similar mechanism for 
activation of nuclear transport. 
p 
IROTEIN growth factors serve as cell-specific mediators 
of cellular communication (11). Through interactions 
with  cell  surface  receptor  proteins,  protein  growth 
factors specific for individual cell types can trigger a reper- 
toire of transcriptional or replicational responses. Although 
much work has detailed the initial event (protein growth fac- 
tor/receptor binding) in the signaling pathway, the means by 
which subsequent mRNA production and transport is acti- 
vated remains  fertile ground for speculation.  Inasmuch as 
protein growth factors are internalized with their receptors 
and transported into the cytoplasmic compartment, a number 
of  groups have explored the possibility that these growth fac- 
tors may be delivered to the nucleus either in free form or 
in association with their respective receptors (7,  13, 22, 31, 
32). Results of  binding studies with insulin (6, 7, 34), epider- 
mal growth factor (EGF) 1  (13), and nerve growth factor (17, 
31, 36, 37) to isolated nuclei and whole cells give evidence 
for protein growth factor receptor localization at the inner 
nuclear membrane/lamina surface. Functionally, in the case 
of nerve growth factor, nuclear binding appears to be essen- 
tial  for the differentiating signals that initiate neurite out- 
growth (31). With regard to insulin,  enhanced mRNA (21, 
30) and macromolecular  transport  (12, 25) have been ob- 
served after insulin addition to isolated nuclei. Recent work 
from our laboratory  has attempted to directly measure the 
effect of insulin and EGF on the bidirectional  transport of 
macromolecules  through  the  nuclear  pore  complex  (25). 
These  measurements  demonstrated  that  insulin  and EGF 
could significantly enhance macromolecular transport in iso- 
lated nuclei within the concentration range used for assessing 
the binding of insulin and EGF to nuclear and plasma mem- 
brane receptors. Here we extend these studies to in vivo sys- 
1. Abbreviations used in this paper:  EGF, epidermal growth factor; KMuSV, 
Kirsten murine sarcoma virus. 
tems. Enhancement (about threefold) of nucleocytoplasmic 
transport  is observed in 3T3-1 and BALB/c 313 fibroblasts 
stimulated by the addition of insulin or EGE Such an EGF- 
induced transport rate enhancement is not observed for 3T3- 
NR6 fibroblasts, a mutant cell line not expressing the EGF 
receptor (20, 29). Shape appears to have a role in these pro- 
tein  growth  factor responses,  since  cells  maintained  in a 
spherical state during measurements do not demonstrate en- 
hanced nuclear transport as a function of  protein growth fac- 
tor addition. Of particular  interest is the result that nuclear 
transport in Kirsten murine sarcoma virus-transformed (313- 
KMuSV) BALB/c 3T3 fibroblasts is already maximally  stim- 
ulated in the absence of insulin and EGE Subsequent addi- 
tion of these growth factors has little effect. 
The  data  presented  here  may be  interpreted  to suggest 
that:  (a) protein growth factors enhance the bidirectional, 
diffusion-mediated nuclear transport of macromolecules in 
3T3  fibroblasts;  (b)  transport  is correlated  with receptor- 
ligand affinity; (c) response in untransformed cells is related 
to cell  shape;  and (d) transformed  fibroblasts have max- 
imally stimulated nuclear transport rates and are refractory 
towards exogenously supplied insulin and EGE The latter re- 
sult would suggest that the mechanisms of protein growth 
factor and oncogenic stimulation that have similarities at the 
transmitter  side of the cellular  signaling pathway (plasma 
membrane-receptor level) may also share common activa- 
tion features at the putative receiver (nuclear surface). 
Materials and Methods 
Reagents 
Fluorescein-labeled dextrans (20,000 and 70,000 mot wt, designated 20K 
and 70K, respectively) and thymidine were obtained from Sigma Chemical 
Co. (St. Louis, MO). Tritiated thymidine (10 Ci/mmol) was from ICN Radio- 
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Gibco (Grand Island, NY); Collaborative Research, Inc. (Lexington, MA), 
and Sigma Chemical Co.,  respectively.  Plasma fibronectin (bovine) was 
purchased from Calbiochem-Behring Corp. (La Jolla, CA). Bovine insulin 
chain A was from Sigma Chemical Co.  Untransformed BALB/c A31 and 
Kirsten murine sarcoma  virus-transformed 3T3  BALB/c  A31  and 3T3-1 
(3T3-Swiss albino) cell lines were obtained from American Type Culture 
Collection (Rockville,  MD).  The 3T3-NR6  EGF nonresponsive cell line 
isolated from murine Swiss albino 313 cells was a kind gift of Dr.  H.  R. 
Herschman, Laboratory of Biomedical and Environmental Sciences, Uni- 
versity of California, School of Medicine (Los Angeles, CA). 
Cell Growth and Synchrony 
The double thymidine block was applied to induce synchrony at the G~/S 
interphase for BALB/c 313, 3T3-1 (Swiss 3T3), and Kirsten murine sarcoma 
virus (KMuSV)-transformed BALB/3T3.  1.2  x  106 cells were plated on 
75 cm  2 tissue/culture flask and grown in DME  supplemented with  10% 
calf serum and 3 mM thymidine, After 18 h, the medium was changed to 
a fresh medium lacking thymidine. After another 6-h incubation and wash- 
ing, 3 mM thymidine was added again for a 24-h culture, followed by wash- 
ing two times with DME.  80-90%  of the cells then were released into 
GdS interphase synchronously (1) as indicated in DNA synthesis assay and 
were then ready for fluorescein dextran scrape-loading. 
Fluorescent Dextran Incorporation into Fibroblasts 
and Cellular Fluorescence Analysis 
The synchronized cells were subjected to the scrape-loading procedure (18), 
as modified by us (26), using 10 mg/ml of 20K or 70K fluorescein dextrans 
in DME.  GI/S phase cells, after scrape-loading, were suspended in DME 
and replated in 35-ram tissue culture dishes for '~3 h. Both spherical and 
spread cell samples were then ready for nuclear fluorescence photobleach- 
ing (12,  16, 25, 26) or fluorescence intensity (ACAS 470 Interactive Laser 
Cytometer; Meridian Instruments, Inc., Okemos, MI) (28, 35) within 1-3 h. 
Nuclear Fluorescence Photobleaching of  Fibroblasts 
and Cell Fluorescence Analysis 
Lang et al. (16) point out that an important consideration in performing nu- 
clear photobleaching in vivo is that tissue culture cells usually display a 
large nucleoplasmic/cytoplasmic volume ratio. The subsequent bleaching of 
the nucleus renders most of the cellular fluorescent pool nonfluorescent and 
results in a  recovery to an equilibrium value that is much lower than the 
prebleach fluorescence intensity. The problem in the interpretation of this 
data, as clearly formulated by Lang et al. (16), is that the influx rate constant 
K, which under conditions of an infinitely large cytoplasmic pool of fluores- 
cent probe, is independent of the cytoplasmic volume: 
K  =  (SN/V~)P, 
where SN and V~ are the surface area and volume of the nucleus, respec- 
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Figure 1.  DNA Synthesis in subcultures started at GdS  inter- 
phase cells.  3T3-B fibroblasts synchronized by double thymidine 
blocking were subcultured  into 12-well tissue culture cluster (•1 
x  105  cells/ml  DME  containing  10%  calf  serum).  Time  zero 
started at  1 h  after release from thymidine blocking.  At the indi- 
cated times (o), they were incubated for l-h periods with tritiated 
thymidine  (10  Ci/mmol)  and  incorporation  into DNA  was  mea- 
sured with an LC  100C counter (liquid scintillation system; Beck- 
man Instruments,  Inc.,  Palo Alto,  CA). 
tively, Under conditions of comparable nuclear and cytoplasmic volume, 
however, K is represented as: 
K  =  [SN(1/VN  +  1/Vc)]P, 
where Vc is the cytoplasmic volume. Incomplete recoveries under the lat- 
ter scenario could either represent a volume effect or an immobile fraction. 
We attempted to overcome this problem of interpretation by using two tech- 
nical approaches.  To insure a  metabolically homogeneous population of 
cells for analysis and to minimize cell-to-cell volume and extent of attach- 
ment variation, we chose to synchronize our cell cultures. Careful selection 
of single living cells was performed to insure a large Vc/VN ratio. In addi- 
tion, we enhanced our fluorescent probe signal by scrape-loading rather 
than microinjecting.  Concentrations of 0.3-0.5  mM  fluorescent dextrans 
could be reached as opposed to ~10 txM for microinjection. Since we had 
sufficient signal to monitor recovery, repeated bleaching could be performed 
on the same cell to properly interpret incomplete fluorescence recovery. 
Fluorescence bleaching experiments were performed as discussed previ- 
ously (12) for isolated nuclei and (26) for whole cells. Interactive laser cyto- 
metric imaging was performed as described previously (28). 
Results 
Cell Synchronization 
Before attempting to measure the effect of protein growth fac- 
tors  on the nuclear transport  of exogenously  incorporated 
fluorescent-labeled dextrans in a single living cell, it was es- 
sential to insure that the geometry of the cells remain approx- 
imately the same for accurate comparisons. In addition, the 
possibility of transport variation as a function of cellular po- 
sition in the cell cycle necessitated an appropriate  means to 
synchronize the ceils. In an attempt to reduce both of these 
sources of cell-to-cell variation,  we chose to synchronize 
our cells  using  double thymidine blocking  (1).  As  calcu- 
lated from tritiated thymidine incorporation measurements, 
BALB/c 3T3 fibroblasts  had an S phase of ~10 h, Gt  ~6 h, 
and G2/M  ~5  h.  This was consistent  with observed dou- 
bling times of 20-21  h for this cell line.  Unless otherwise 
stated,  all measurements  were performed on flat adherent 
(spread)  cells within 4-6 h after releasing. Both 3T3-B and 
3T3-KMuSV  (data  not shown) cells were restricted to the 
GdS interphase in the cell cycle as shown in Fig.  1. 
Fluorescent Dextran Incorporation and Quantitation 
Using the scrape-loading technique originally demonstrated 
by McNeil et al. (18) and modified by us (26), we attempted 
to incorporate fluorescent dextrans of 20000 and 70,000 tool 
wt  into  the  cell  cytoplasm  to  serve  as  neutral  transport 
probes. Since dextrans are not constitutive elements of nor- 
mal  cells  and  should  not  have  potential  nuclear  localiza- 
tion and binding sequences (15), it was felt that these mole- 
cules would be capable of strictly  reflecting  changes in the 
transport rate initiated by protein growth factors. The results 
of this incorporation strategy are presented in Fig. 2. Using 
the ACAS 470 Interactive Laser Cytometer (Meridian Instru- 
ments, Inc.), a pseudo-color map was generated showing dis- 
tribution  of fluorescence intensity.  As can be observed in 
Fig. 2 a, for the 20K dextran, the highest fluorescence inten- 
sities are found in the cell nuclei (arrow), while the cells con- 
taining 70K dextran show cytoplasmic labeling but minimal 
nuclear labeling (Fig. 2 b, arrow). When the data is replotted 
with fluorescence intensity represented  on the z-axis, three- 
dimensional plots of the cellular distribution  of fluorescence 
intensities are created  (Fig.  2, c and d). The peaks in Fig. 
2 c (red tops) clearly show the labeling of the nuclear vol- 
The Journal of Cell Biology, Volume 106,  1988  14 Figure 2. Pseudocoior digitized computer image of fluorescence intensity distribution of 20K and 70K fluorescein-derivatized dextrans 
in BALB/c 3T3 cells. 20K dextrans scrape-loaded into cells (Materials and Methods) reveal nuclear localization (a), while 70K dextrans 
are excluded from the nucleus (b). The images observed in a and b are now presented as a three-dimensional plot with intensity as the 
z-axis; c and d are three-dimensional representations of a and b, respectively. The arrows indicate the internally labeled nucleus. Color 
values are shown with their numerical equivalency. 
ume, while the "crater" appearance of the 70K-incorporated 
cells (Fig.  2 d) are representative of little intranuclear ac- 
cumulation. An important element of this analysis for subse- 
quent transport interpretation is the requirement that the in- 
corporation of labeled dextrans into the cell cytoplasm is 
equivalent,  i.e.,  20K and 70K dextrans are taken up with 
equal efficiency, and that nuclear uptake occurs for a  sig- 
nificant population of cells. Using the ACAS 470, cell popu- 
lations (>100 cells) were analyzed with regard to nuclear 
labeling and equivalency of uptake for 20K and 70K dex- 
trans.  Fig.  3  presents a  series of cell histograms in which 
cellular fluorescence intensity of individual cells is calcu- 
lated through a pixel by pixel integration of the two-dimen- 
sionally imaged cell (as represented by the cell images in Fig. 
2). This analysis is performed on a large number of cells and 
a histogram is prepared relating fluorescence intensity/cell to 
cell number in a  manner directly analogous to cell DNA 
histograms prepared with a fluorescence based flow cytome- 
ter. Since the cells are flat and adhering to the growth sur- 
face, the excited fluorescence will be weighted towards the 
greatest  cellular  volume,  which  is  the  noncompressible 
spherical  nucleus.  In this  manner,  nuclear localization of 
dextrans in whole cells may be quantitated. As observed in 
Fig. 3 a, 104 cells were analyzed with 30% of the cells show- 
ing strong nuclear fluorescence (defined as intensity >8) for 
the 20K dextran and 6% for the 70K dextran (Fig. 3 b). Fig. 
3, c and d demonstrate that the fluorescence/area  of incorpo- 
rated 20K and 70K dextrans presents a  similar profile over 
a cell population, suggesting that the efficiency  of uptake and 
total amount of fluorescent-labeled 20K and 70K incorpo- 
rated into the cells is approximately the same. 
Nuclear Fluorescence Photobleaching 
Because  70K  dextrans  were  shown  to  be  excluded  from 
fibroblast  nuclei,  all  transport  measurements  were  per- 
formed with incorporated 20K fluorescent-labeled dextrans. 
Cells were scanned with a laser beam (argon ion kEx =  488 
nm) and photobleached as described. An example of the data 
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dextran distribution in BALB/c  3T3  fibroblasts, a 
and b are histograms of fluorescent intensities (x-axis) 
for 104 cells scrape-loaded with 20K dextrans, and 
111  cells loaded with 70K  dextrans,  respectively, c 
and d are the same as a  and b, respectively, but rep- 
resent the fluorescence/unit area (pixel). 
obtained is presented in Fig. 4.  An initial series of scans 
demonstrates a prebleach fluorescence level. A photobleach 
was initiated using a beam whose width is approximately that 
of the  labeled  nucleus  (~6  txm  in  diameter).  The  pho- 
tobleaching depletes the fluorescence in the nucleus, result- 
ing in the decrease in intensity observed in scan a  which is 
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Figure 4.  In  vivo fluorescence photobleach of a  BALB/c 3T3 
nucleus  loaded with 20K  fluorescent-labeled dextrans.  The  or- 
dinate is an arbitrary scale of fluorescence intensity, while the ab- 
scissa represents the position of the beam along a  programmed 
scan. Each scan is a pass of the excitation laser beam across the 
nucleus. The interval between two scans, i.e., scan time with de- 
lay, is 5-10 s. A bleaching pulse results in the depletion of nuclear 
fluorescence represented by a; subsequent scans observed at non- 
bleaching excitation levels demonstrate fluorescence recovery (b, 
c, and d). The arrow represents the center of the bleaching pulse. 
The recovery of fluorescence is observed in a monitoring period 
of 2.5-5 min and is proportional to the dextran flux rate (12, 16). 
Beam diameter is ,~6 lim. 
generated immediately after the bleaching event.  Recovery 
of fluorescence as a  result of nucleocytoplasmic transport is 
represented by the return to prebleach fluorescence levels. 
This is indicated by curves b,  c, and d  in Fig. 4  and addi- 
tional unlabeled recovery curves. These recovery curves are 
analyzed and transformed into recovery rates as described. 
This technique was used to measure the nucleocytoplasmic 
transport rate of 20K  dextrans  in BALB/c 3T3  and  3T3-1 
fibroblasts as a  function of EGF concentration. The results 
presented in Fig. 5 demonstrate a saturable dose response for 
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Figure 5.  Dose dependence of EGF on dextran flux in BALB/c3T3 
fibroblasts. The change in the rate of dextran transport of 20K 
fluorescent dextrans from control cells (e).  A  similar measure- 
ment  performed on  isolated rat liver nuclei using  fluorescent- 
labeled 64K dextrans as the probe molecule (&). 
The Journal of Cell Biology, Volume  106,  1988  16 Table L Effect of Cell Shape on Nucleocytoplasmic  Transport of  20K Dextrans in 3T3 Fibroblasts 
Transport Rate* 
Conditions*  3T3- I  BALB/c 3T3-KMuSVw 
Spreadll 
Spherical** 
Spherical  +  40 ng/ml EGF 
Spherical  +  500 ng/ml EGF 
10-3 s-I 
6.4  •  1.6'1 (8)** 
6.4  +  1.3  (8) 
6.2  +  0.5 (8) 
8.6  +  2.5 (10) 
10  -~ s-' 
18.9  +  4.3  (7) 
12.0  •  2.0 (9) 
* Transport rate constant of 20K dextran molecules. 
* Cells in G,IS interphase were obtained as described in Materials and Methods. 
w  KMuSV-transformed BALB/3T3 fibrobtasts. 
tl Cells were grown in DME (no calf serum supplement) and spread on 35-mm tissue culture dishes coated  with fibronectin  (50 Izg/dish). 
￿82 Mean  5:  SD. 
** Number of experiments. 
,5 Cells were suspended in DME (no calf serum) immediately after scrape-loading with 20K dextrans. 
EGF on nucleocytoplasmic transport in 3T3-B fibroblasts. 
All transport measurements were performed 1-2 h after add- 
ing EGF to the culture medium and incubation at 37~  The 
nuclear transport rates dropped ~40% after 6-h incubation. 
This may be related to the reported decrease in EGF binding 
after ~6 h at 37~  (2). For comparison, the same series of 
measurements are presented for isolated rat liver nuclei (Fig. 
5).  Although the transport rate enhancement was  *2.5-3- 
fold higher in isolated rat liver nuclei (using 64K-mol-wt dex- 
trans, the diameter of the nuclear pore complex in isolated 
rat liver nuclei appears to be larger [12, 16]), the concentra- 
tion for half-maximal enhancement was approximately the 
same for both, 20-25 ng/ml ("~3-4 nM). 
Effect of  lnsulin and EGF on 313 and 
Kirsten Murine Sarcoma Virus-transformed 
3T3 Fibroblasts 
The  previous  results  suggested  that  a  dose  dependent 
modification of nuclear macromolecular transport could be 
observed for EGF. More importantly, these effects occurred 
within  the  concentration  range  of EGF  used  for  recep- 
tor-EGF-binding studies (from nuclear accumulation stud- 
ies,  on 3T3-1, half-maximal binding to nuclei occurred at 
~1-3 nM EGF; M.  Schindler and L.-W. Jiang, manuscript 
in  preparation).  The  next question  pursued  was  whether 
EGF and insulin could also affect this transport in trans- 
formed cells. For this study, KMuSV-transformed BALB/c 
3T3 fibroblasts were used. The results of these experiments 
are presented in Tables I and II. Table I establishes that trans- 
formation results  in  an  enhancement  of macromolecular 
transport by ",,200% over control when cells are attached and 
spread on the growth surface. Of particular interest is the ap- 
parent shape dependency for transport noted for the trans- 
formed cells.  Spherical  3T3-KMuSV  cells  (nonadhering) 
have decreased transport rates, while 3T3-1 rates remain un- 
changed.  Significantly though,  untransformed cells in the 
Table II. Effect of  Protein Growth Factors and Transformation on Nucleocytoplasmic  Transport 
Dextran transport rate* 
Conditions*  3T3-1  BALB/c 3T3-KMuSVw 
10-3 s-I  10-~ s-I 
Control  (spread)ll  6.4  +  1.61  (8)**  18.9  •  4.3  (7) 
+  10 ng/ml EGF**  11.3  •  1.6  (6)  - 
+  20 ng/ml EGF  14.3  +  2.6  (7)  - 
+  50 ng/mt EGF  19.8  •  3.7  (8)  - 
+  500 ng/ml EGF  19.7  _+  3.0 (19)  19.4  •  2.6 (7) 
+  Boiled  500 ng/ml EGF  6.7  •  1.2 (8)  19,0  •  2.0 (5) 
+  40 ng/ml insulin  14.6  +  2.2 (5)  - 
+  500 ng/ml insulin  18.9  •  2.7 (13)  21.0  •  4.7  (12) 
+  Boiled  500 ng/ml insulin  6.9  +  1.6 (8)  20.2  +_  3.4 (5) 
+  0.1  gg/ml insulin A  chain  7.0  +  1.1  (9)  - 
+  5  Ixg/ml glucagon  7.2  +  2.6 (9)  21.0  •  4.0 (6) 
+  10%  calf serumw167  10.7  +  2.7 (12)  22.0  •  3.5  (18) 
-  Fibronectinlll[  6.8  •  1.3  (8)  - 
* Transport rate constant of 20K dextran molecules. 
5 Cells in GJS interphase were obtained as described in Materials and Methods. 
w  KMuSV-transformed BALB/3T3 fibroblasts. 
II Cells were grown in DME (no calf serum) and spread on 35-mm tissue culture dishes coated with 50 ~tg/dish fibronectin, no EGF or insulin addition. 
Mean _4- SD. 
** Number of experiments. 
5, Transport measurements were performed after adding EGF to culture medium and incubating at 37~  for 1-2 h. 
w167  Cells were growing in DME containing t0% calf serum. 
lilt Ceils were growing in DME and spread on tissue culture dishes without fibronectin coating. 
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ulation of nuclear transport even at extremely high EGF con- 
centration (500 ng/ml). Table II shows that insulin and EGF 
are capable of significantly enhancing transport in untrans- 
formed cells, while boiled insulin and boiled EGF have no 
such effect. Glucagon and insulin A chain, at high concentra- 
tions, also did not affect transport. The effect of fibronectin 
removal was also examined and found to be without conse- 
quence as long as the cells remained attached and spread. 
The addition of calf serum to spread cells, as might be ex- 
pected considering its content of growth factors, proved to be 
stimulatory. Of particular note is the observation that insulin 
and EGF had no effect on the already enhanced transport rate 
observed for the KMuSV-transformed cells (Table II). 
Effect of  EGF  on Nuclear Transport in 
3~-NR6 Fibroblasts 
Pruss and Herschman (20)  isolated an EGF-nonresponsive 
cell line from murine Swiss albino 3"13 fibroblasts.  Analysis 
of this EGF-nonresponsive variant demonstrated the absence 
of EGF receptor-related molecules and mRNA for the EGF 
receptor (29). When 20K dextran nuclear transport was ex- 
amined in these cells under adherent conditions as described 
in Materials and Methods and Tables I and II, the addition 
of 200 ng/ml of EGF did not induce any transport rate en- 
hancement. The rate in 3T3-NR6 without EGF was 7.1 •  1.0 
￿  10-3s  -I,  while in the presence of EGF (200 ng/ml) the 
transport rate constant is 7.4  +  1.5  ￿  10-3s-L These values 
are nearly identical  to control 3T3-1 fibroblasts and provide 
evidence that the EGF stimulation is receptor mediated. 
Discussion 
"Peptide hormone interactions with nuclei are a class of an- 
noying data produced by good investigators, that is a class 
of pests that won't go away and that must be noticed" (quota- 
tion from an anonymous Journal of Cell Biology reviewer). 
Previous results provided evidence that EGF and insulin 
significantly stimulated macromolecular transport across the 
nuclear pore complex in isolated rat liver nuclei. This trans- 
port enhancement was demonstrated to be dose dependent 
and found to occur in the concentration range of reported 
physiological responses to these protein growth factors, e.g., 
nanomolar range (29).  In consideration of these  in  vitro 
results,  it may be  appropriate  to  suggest that the protein 
growth factor stimulation of 3T3 fibroblast nuclear transport 
is dependent upon the delivery of protein growth factor or 
the growth factor/receptor complex to the nuclear surface. 
This may not only be inferred from the in vitro nuclear acti- 
vation results (2i, 25, 30), but is consistent with morphologi- 
cal evidence localizing monomeric ferritin-labeled insulin 
after 1-2 h to the perimeter of condensed chromatin, in par- 
ticular near nuclear pores in 3T3-L1 adipocytes (32).  Other 
morphological investigations also suggest a perinuclear lo- 
calization of endocytosed protein growth factor receptors (8, 
19). A chromatin localization for EGF, nerve growth factor, 
and  platelet-derived  growth  factor  was  also  reported  by 
Rakowicz-Szulczynska et al. (22) after cellular subfractiona- 
tion. The similarity between the dose dependency for protein 
growth factor binding to plasma membrane receptors (2-4, 
24) and the dose response for activation of nuclear macro- 
molecular transport suggest that either the nuclear protein 
growth factor/receptor complex is translocated from the cell 
surface and maintained in dynamic equilibrium with surface 
receptors, or indigenous nuclear receptors exist at the inner 
nuclear membrane/matrix interface that have similar protein 
growth factor-binding properties to plasma membrane re- 
ceptors. These putative nuclear protein growth factor recep- 
tors would be activated by the delivery of protein growth fac- 
tor from the plasma membrane. 
Shape Modulation of  Nuclear Transport 
Our observation that shape plays a role in the protein growth 
factor stimulation of nuclear activity (spherical cells showed 
no nuclear transport enhancement as a  function of added 
EGF) may be viewed in the context of demonstrations by 
Folkman and Moscona (5) that cell shape is tightly coupled 
to DNA synthesis, growth, and cellular response to growth 
factors. Our results now refine these observations to suggest 
that nucleocytoplasmic transport may be an important con- 
trol  point  for  shape  modulation of cellular activity.  The 
observation that spread and spherical cells have similar nu- 
clear transport rates in the absence of calf serum or protein 
growth factors implies that under these limiting conditions, 
a relative basal transport rate is achieved that can then be en- 
hanced only in the spread state after addition of EGF (Table 
I) or 10% calf serum (Table II). A model may be envisioned 
in which the mediation of a protein growth factor signal re- 
quires the organization of transport routes for the protein 
growth factor/receptor complex between the plasma mem- 
brane and nuclear surface. These transport tracks exist fully 
organized in nontransformed spread adhering cells, but not 
in spherical cells. 
Transformation Enhances Nuclear Transport 
Transformation of 3T3 fibroblasts with KMuSV results in 
maximal nuclear transport rates. Addition of high amounts 
of EGF, insulin (500 ng/ml), or I0% calf serum have no fur- 
ther enhancing effect.  These observations fit well with the 
concept that transformed cells are  self-stimulating (auto- 
crine) and no longer require external protein growth factors 
(33).  Since shape modification in this instance alters nuclear 
transport activity slightly, it may be possible that although 
autocrine self-stimulation appears to bypass normal cellular 
shape  response  mechanisms,  some cellular structures for 
signal transmission are still moderately responsive to shape 
alteration. 
Protein Growth  Factor  Nuclear-signaling  Pathway: 
How Many Nuclear Receptors  Are Enough? 
In this discussion, we have presented evidence that protein 
growth factor-induced nuclear stimulation reflects growth 
factor/receptor  occupancy  at  the  nuclear  surface.  Under 
most assay conditions, the amount of protein growth factor 
found in the nucleus may be <2 % of the total growth factor 
binding to the cell (13, 24, 32; L.-W. Jiang and M. Schindler, 
unpublished results). Is a 2 % protein growth factor delivery 
efficiency sufficient to modify nuclear activity? In this con- 
text, it should be noted that although >90% of interna.lized 
growth factor/receptors may be targeted to the lysosomes (14, 
19) or transported to other intracellular targets, the number 
of functional activated receptors necessary to induce trans- 
The Journal of Cell Biology,  Volume  106, 1988  18 port changes in the nucleus may be small.  Protein growth 
factor receptors, in the presence of ligand, have been demon- 
strated to function as tyrosine kinases with very low activity 
in the absence of the ligand (10). Upon growth factor binding, 
endogenous enzymatic activity is greatly  stimulated in the 
manner  of allosteric  activation,  resulting  in  an  activated 
receptor enzyme or "receptorzyme"  (27).  The activation  of 
enzymatic activity would suggest that only a small number 
of receptorzymes need be captured  by the nucleus to either 
activate  indigenous nuclear receptorzymes or directly affect 
a number of mechanisms that result in the alteration  of nu- 
clear transport properties. Evidence now exists which shows 
that changes in polyphosphoinositide metabolism and phos- 
phorylation/dephosphorylation of nuclear envelope compo- 
nents can vary the structural and transport properties of the 
nuclear pore complex (12, 21).  Both biochemical signaling 
events have been associated with protein growth factor stimu- 
lation and oncogene-mediated transformation  (9, 23). Previ- 
ous reports in the literature provide good evidence that trans- 
formation of cells permit growth factor autonomous growth 
which is suggested to reflect an alteration  of protein growth 
factor receptor or postreceptor-signaling pathway (33). Our 
results now extend these observations to show that transfor- 
mation also results in the augmentation of the protein growth 
factor receptor response pathway to make nuclear transport 
activation independent of exogenous protein growth factor 
concentration.  The results  reported  extend the analysis of 
cellular signaling from the cell surface to the nuclear enve- 
lope. Specific transport steps, particularly  in relation to orga- 
nized  transcellular  cytoskeletal  pathways  between the  two 
signaling  sites,  and the nature of the nuclear envelope as- 
sociated activator  are presently under investigation. 
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